Psychiatry and Neurology, Neurology · Lehigh Acres, FL
NPI
1760442057
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
228 Plaza Dr, Suite E
Lehigh Acres, FL, 33936
Phone (239) 368-7260
Medicare paid, 2024
$22K
243 services
Medicare patients, 2024
87
Average age 72
Drug cost, 2024
$4.7M
2,748 prescriptions
Company payments, 2025
$1,335
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Randolph S Geslani was code 99214 (office e&m - established), 132 times for 52 patients. In total Randolph S Geslani billed 243 services in 7 codes, and Medicare paid $22K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-02-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 132 | 52 | $82.00 | $11K |
| 99215 Office E&M - Established | Office | 30 | 26 | $140.26 | $4,208 |
| 99205 Office E&M - New | Office | 29 | 29 | $147.29 | $4,271 |
| 99213 Office E&M - Established | Office | 28 | 18 | $44.39 | $1,243 |
By year: 2022 $28K for 282 services; 2023 $24K for 254 services; 2024 $22K for 243 services.
Medicare prescription drug claims, 2024
In 2024, the drug Randolph S Geslani prescribed most often to Medicare patients was Austedo (Deutetrabenazine), with 205 prescriptions and refills. In total Randolph S Geslani wrote 2,748 Medicare prescriptions that cost $4.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Austedo Deutetrabenazine | 205 | 205 | 24 | $1.9M |
| Austedo Xr Deutetrabenazine | 117 | 123 | 15 | $1.5M |
| Qulipta Atogepant | 101 | 101 | 15 | $110K |
| Alprazolam Generic | 99 | 100 | 13 | $573 |
| Nuedexta Dextromethorphan Hbr/Quinidine | 98 | 98 | 15 | $138K |
| Levetiracetam Generic | 90 | 199 | 18 | $5,957 |
| Donepezil Hcl Generic | 87 | 184 | 26 | $812 |
| Gabapentin Generic | 86 | 151 | 23 | $1,656 |
| Carbidopa-Levodopa Carbidopa/Levodopa | 80 | 191 | 28 | $1,562 |
| Lorazepam Generic | 76 | 76 | 16 | $337 |
| Nurtec Odt Rimegepant Sulfate | 74 | 74 | Under 11 | $108K |
| Memantine Hcl Generic | 64 | 133 | 19 | $2,210 |
| Aptiom Eslicarbazepine Acetate | 58 | 58 | Under 11 | $74K |
| Ubrelvy Ubrogepant | 58 | 58 | Under 11 | $73K |
| Clonazepam Generic | 54 | 55 | Under 11 | $595 |
Brand drugs: 1,099 claims; generic drugs: 1,649 claims; opioid claims: 37.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Randolph S Geslani $1,335 ($1,335 in general payments such as food, travel and fees) from 11 companies. The largest payer was Teva Pharmaceuticals USA, Inc. with $373.
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. TEVA | 24 | $373 |
| Abbvie Inc. ABBV | 13 | $247 |
| Neurocrine BioSciences, Inc. NBIX | 11 | $192 |
| Biogen, Inc. BIIB | 8 | $174 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 12 | $144 |
| Novartis Pharmaceuticals Corporation NVS | 3 | $56.73 |
| Janssen Biotech, Inc. JNJ | 3 | $47.54 |
| Genentech USA, Inc. ROG.SW | 2 | $43.38 |
| Lundbeck LLC | 1 | $21.69 |
| ACADIA Pharmaceuticals Inc ACAD | 1 | $20.65 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.